Key indicators: single-crystal X-ray study; T = 293 K; mean (C-C) = 0.003 Å; disorder in main residue; R factor = 0.039; wR factor = 0.099; data-to-parameter ratio = 9.1.
In the title molecule, C 30 H 35 NO 8 , the acenaphthylenone moiety, two atoms of a methyl pyrrolidine ring (N and C atoms) and four atoms of an ethyl acetate moiety (two C and two O atoms) are disordered over two sets of sites in ratio 0.532 (7):0.468 (7). The three C atoms of a dimethoxyethane ring and dioxolane ring attached with two methyl groups are disordered over two sets of sites in 0.66 (2):0.34 (2) and 0.62 (2):0.38 (2) ratios, respectively. The major and minor components of the acenaphthylene ring are essentially planar (r.m.s. deviations = 0.0254 and 0.0436 Å , respectively). The major and minor components of the pyrrolidine ring adopt Cenvelope conformations with C atoms displaced by 0.492 (11) and 0.595 (7) Å from the remaining ring atoms. One of the dioxolane rings is disordered with its major component in an envelope conformation [C displaced by 0.511 (11) Å ] and the minor fraction is more or less planar with an r.m.s. deviation of 0.070 Å . The other dioxolane ring is in an envelope conformation, with a C atom displaced by 0.438 (3) Å from the remainder of the ring atoms. The crystal packing features C-HÁ Á ÁO interactions, which generate C(9) chains.
Related literature
For biological properties of spiroheterocycles, see: Kilonda et al. (1995) ; Ferguson et al. (2005) . For a related crystal structure, see: Jagadeesan et al. (2012) .
Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ). (Farrugia, 2012) ; software used to prepare material for publication: SHELXL97 and PLATON (Spek, 2009).
Comment
The design and novel synthesis of glycospiroheterocycles are interesting because of the synthetic challenges they present and their biological profile against viruses, bacteria, and cancer cells (Ferguson et al., 2005) . Pyrrolidines and pyrroles are common structural motifs in drugs and drug candidates owing to their ability to act as selective glycosidase inhibitors, which are used in the treatment of diabetes, cancer, malaria and viral infections, including AIDS (Kilonda et al., 1995) .
In the title molecule, the acenaphthylenone moiety (O1, C1-C12), two atoms of a methyl pyrrolidine ring (N1 & C11) and four atoms of an ethyl acetate moiety (O2, O3, C18 & C19) were disordered over two sites in ratio 0.531 (7):0.469 (7). The three C atoms of a dimethoxyethane ring (C25, C26 & C27) and two methyl C atoms (C29 & C30) attached to a dioxolane ring were disordered over two sites in ratios 0.659 (2):0.341 (2) and 0.615 (7): 0.385 (7), respectively. The bond distances and angles in the title compound ( Fig. 1 ) agree very well with the corresponding bond distances and angles reported in a closely related compound (Jagadeesan et al., 2012) .
The major and minor components of the acenaphthylene ring (O1/C1-C12 and O1′/C1′-C12′) are essentially planar (rmsd 0.0254 and 0.0436 Å, respectively). The major and minor components of pyrrolidine (C11/C14-C16/N1 & C11′/C14-C16/N1′) adopt C11-and C14-envelope conformations with C atoms displaced by 0.492 (11) and 0.595 (7) °, respectively, from the remaining ring atoms. One of the dioxolane rings is disordered with major component (O5/O6/C21/C22/C25) in a C25-envelope conformation (C25 displaced by 0.511 (11) Å from the remining ring atoms) and the minor fraction (O5/O6/C21/C22/C25′) is more or less planar with rmsd 0.070 Å. The other dioxolane ring (O7/O8/C23/C24/C28) is in a C28-envepole conmformation with C28 displaced by 0.438 (3) Å from the rest of the ring atoms.
The dihedral angle between the mean planes of the major acenaphthylenone moiety (C1-C12/O1) and major pyrrolidine ring (C11/C14/C15/C16/N1) is 82.91 (2)°, which shows they are almost orthogonal to each other. The mean plane of the pyran ring (C20-C24/O4) forms dihedral angles of 71.40 (2)° and 73.35 (1)° with the mean planes of the major dioxolane ring (C21/C22/C25/O5/O6) and undisordered dioxolane ring (C23/C24/C28/O7/O8), respectively.
The crystal packing is stabilized by C23-H23···O1 intermolecular interaction (Table 1 & Fig. 2 ) that generates a C (9) chain running along the c-axis.
Experimental
A mixture of (E)-ethyl 3-((3aR,5R,5aS,8aS,8bR)-2,2,7,7 -tetramethyltetrahydro-3aH-bis [1, 3] dioxolo [4,5 -b:4′,5′-d] pyran-5-yl)acrylate (0.915 mmol, 300 mg), acenaphthenequinone (0.915 mmol, 166 mg) and sarcosine (1.0 mmol, 97 mg) was refluxed in toluene for about 7 h under Dean stark reaction condition to give the title compound in good yield.
Figure 1
The molecular structure of the title compound with the atom numbering scheme, displacement ellipsoids are drawn at 
